Cargando…

Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection

OBJECTIVE: Liver inflammatory activity staging is critical to guide the treatment of chronic hepatitis B virus (CHB) infection. Here, we aimed to identify practical clinical biomarkers of moderate inflammatory activity in hepatitis B e-antigen (HBeAg)-negative CHB patients. METHODS: Treatment-naïve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jianhua, Wang, Yong, Jiang, Gongying, Zheng, Jie, Chen, Tuxiang, Chen, Zhiping, Yang, Meifang, Zhang, Xuan, Zhao, Hong, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673054/ https://www.ncbi.nlm.nih.gov/pubmed/33179557 http://dx.doi.org/10.1177/0300060520969582

Ejemplares similares

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B
por: Hu, Jianhua, et al.
Publicado: (2019)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
por: Chi, Xiu-Mei, et al.
Publicado: (2021)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
por: Xu, Baiguo, et al.
Publicado: (2022)

Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
por: Riveiro-Barciela, Mar, et al.
Publicado: (2021)

Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection
por: Zhang, Lu, et al.
Publicado: (2017)

Clinical features of acute hepatitis E super-infections on chronic hepatitis B
por: Chen, Chong, et al.
Publicado: (2016)

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
por: Nirmala, Viva Finhar Insani, et al.
Publicado: (2023)

Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon
por: Luo, Wenfan, et al.
Publicado: (2021)

Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B
por: Zheng, Ying, et al.
Publicado: (2023)

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Li, Tai-Ping, et al.
Publicado: (2019)

The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients
por: Tan, Lei, et al.
Publicado: (2021)

Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers
por: Zhang, Wenjun, et al.
Publicado: (2022)

Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
por: Huang, Bi-Xia, et al.
Publicado: (2020)

Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2019)

Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B
por: Wang, Rui, et al.
Publicado: (2023)

Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
por: Alpsoy, Anil, et al.
Publicado: (2022)

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
por: Broquetas, Teresa, et al.
Publicado: (2020)

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
por: Ahn, Jem Ma, et al.
Publicado: (2015)

Lymphocyte-to-white blood cell ratio is associated with outcome in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Zhang, Yue, et al.
Publicado: (2023)

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017)

Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study
por: Krastev, Zahari, et al.
Publicado: (2016)

High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B
por: Laras, Andreas, et al.
Publicado: (2022)

Perinatal transmission in infants of mothers with chronic hepatitis B in California
por: Burgis, Jennifer C, et al.
Publicado: (2017)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B
por: Wang, Jian, et al.
Publicado: (2022)

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
por: Chang, Ming-Ling, et al.
Publicado: (2022)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study
por: Chen, Yu-Jung, et al.
Publicado: (2017)

Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China
por: Wu, Wei, et al.
Publicado: (2017)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
por: Marcellin, Patrick, et al.
Publicado: (2012)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China
por: Li, Runqin, et al.
Publicado: (2021)

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_81jdr4qpcqjdmp13bsmoln37lr